Navigation Links
Boston Scientific Agrees to Sell Neurovascular Business to Stryker
Date:10/28/2010

n the operations of the Neurovascular business, the planned divestiture does not meet the criteria for presentation as a discontinued operation.  Accordingly, all historical financial results of the Neurovascular business will continue to be included in the Company's results from continuing operations for all periods presented.  In periods subsequent to closing, the Company's results will include only net sales to Stryker and an immaterial amount of gross profit related to those sales.

Boston Scientific established its Neurovascular business with the acquisition of Target Therapeutics in 1997.  Headquartered in Fremont, California, the Neurovascular business is a leading developer of less-invasive medical technologies used to treat brain aneurysms and other types of cerebrovascular disease.  The business employs approximately 1,150 people and reported 2009 revenues of $348 million.

"The sale of our Neurovascular business is part of our overall strategic plan that will refocus our portfolio to, amongst other criteria, leverage existing sales forces with least invasive, cost and comparatively effective medical devices that reduce or eliminate refractory drug regimens," said Ray Elliott, President and Chief Executive Officer of Boston Scientific.  "The proceeds from this sale will allow us to invest in future growth opportunities more aligned with that strategy while also reducing overall debt leverage.""We deeply appreciate the contributions of our Neurovascular employees and wish them continued success going forward in this new venture," added Elliott.  "We believe this transaction will prove to be a win-win for all parties."

About Boston ScientificBoston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties.  For more information, please visit: www.bostonscien
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007
3. Boston University Biomedical Engineers Find Chink in Bacterias Armor
4. Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007
5. Preliminary Results of Randomized Pilot Study Show Comparable Efficacy for OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) and Boston Scientifics Taxus(R) Stent in Patients at High Risk of Restenosis
6. Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures
7. Boston Scientifics Next-Generation Stent Shows Improved Clinical Outcomes in Complex Lesions
8. Positive Five-Year Safety Data for TAXUS(R) Stent Reported in Boston Scientific Trial
9. Boston Scientific Carotid Artery Stenting Trials Produce Positive Three-Year Results
10. Award-Winning Medicine Wheel Returns to the Cyclorama at the Boston Center for the Arts on Dec. 1 for 24-hour Vigil Recognizing World AIDS Day
11. Boston Scientific Announces CE Mark Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2014)... AVIV, Israel , July 21, 2014 ... a clinical-stage biopharmaceutical company focused on the development and ... of liver diseases and cholesterol gallstones, announced today that ... Friday, July 25, 2014 to discuss results for the ... update on current developments with respect to its clinical ...
(Date:7/21/2014)... , July 21, 2014  Zacks.com announces the list ... Zacks Equity Research analysts discuss the latest news and events ... the blog include the Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH - ... Report ), Eli Lilly and Company (NYSE: LLY - ... ) and InterMune, Inc. (Nasdaq: ITMN - Free Report ...
(Date:7/21/2014)... DIEGO , July 21, 2014 Sorrento ... late-stage clinical oncology company developing new treatments for cancer ... received non-dilutive funding for the preclinical development of a ... Myc. The Myc protein has also ... and protein synthesis. It is involved as a dominant ...
Breaking Medicine Technology:Galmed Pharmaceuticals Second Quarter 2014 Conference Call and Webcast Scheduled for Friday, July 25, 2014 2The Zacks Analyst Blog Highlights: Anthera Pharmaceuticals, Amgen, Eli Lilly, Actelion and InterMune 2The Zacks Analyst Blog Highlights: Anthera Pharmaceuticals, Amgen, Eli Lilly, Actelion and InterMune 3The Zacks Analyst Blog Highlights: Anthera Pharmaceuticals, Amgen, Eli Lilly, Actelion and InterMune 4The Zacks Analyst Blog Highlights: Anthera Pharmaceuticals, Amgen, Eli Lilly, Actelion and InterMune 5The Zacks Analyst Blog Highlights: Anthera Pharmaceuticals, Amgen, Eli Lilly, Actelion and InterMune 6The Zacks Analyst Blog Highlights: Anthera Pharmaceuticals, Amgen, Eli Lilly, Actelion and InterMune 7Sorrento Awarded Grant from the National Institutes of Health for the Development of a Small Molecule Myc Inhibitor 2Sorrento Awarded Grant from the National Institutes of Health for the Development of a Small Molecule Myc Inhibitor 3Sorrento Awarded Grant from the National Institutes of Health for the Development of a Small Molecule Myc Inhibitor 4
...  Communication channels are becoming increasingly plentiful in today,s ... drive efficient performance, increase profitability and raise consumer ... companies need to identify which external and internal ... best use them. Best Practices, ...
... 2012  Par Pharmaceutical Companies, Inc. (NYSE: ... the acquisition of privately-held Edict Pharmaceuticals Private Limited, ... Par paid $20.5 million at closing and $4.4 ... Edict is a Chennai, India-based developer and manufacturer ...
Cached Medicine Technology:Effective Communication Options to Increase Organizational Effectiveness 2Par Pharmaceutical Completes Acquisition of Edict Pharmaceuticals 2
(Date:7/22/2014)... 2014 An Ideal Location , Narconon ... the naturally tranquil and very beautiful Arrowhead State Park, ... ideal for both a rehabilitative setting, as well as ... display of fireworks. Launched over the waters of ... swimming in the lake, or from the nearby campgrounds ...
(Date:7/22/2014)... UT (PRWEB) July 22, 2014 MonaVie ... joins its Scientific Advisory Board (SAB). The addition of ... expertise to support current product development plans and necessary ... stranger to MonaVie, Macdonald has been with the company ... was influential in helping formulate MonaVie’s RVL ...
(Date:7/22/2014)... (PRWEB) July 22, 2014 Joining Conquer Paralysis ... paralysis in the next decade is Paralympic silver medalist and ... accident, French became a quadriplegic from a spinal cord injury ... help find a cure for paralysis. , “People define cure ... others, it’s something else. We have the image in our ...
(Date:7/22/2014)... (PRWEB) July 22, 2014 Ocean ... center located in Pompano Beach, Florida, has ... the Joint Commission, an independent not-for-profit organization that ... Accreditation signifies that the quality programs offered at ... standards for safety and performance. Ocean Breeze, which ...
(Date:7/22/2014)... JumpSoft, Inc., a next generation software ... the application level, today released its “App-Hugger” report ... , Based on in-depth, one-on-one interviews ... insights, context and depth regarding the challenges facing ... uptime. London, Ink, a B2B marketing consulting firm, ...
Breaking Medicine News(10 mins):Health News:Narconon Arrowhead Holds Annual Firework Event 2Health News:Narconon Arrowhead Holds Annual Firework Event 3Health News:MonaVie Adds Nutritionist Mark Macdonald to Its Scientific Advisory Board 2Health News:MonaVie Adds Nutritionist Mark Macdonald to Its Scientific Advisory Board 3Health News:Paralympian Jen French Announced as Conquer Paralysis Now’s First Champion 2Health News:Florida Drug and Alcohol Addiction Treatment Center Receives Joint Commission Seal of Approval 2Health News:Florida Drug and Alcohol Addiction Treatment Center Receives Joint Commission Seal of Approval 3Health News:JumpSoft Releases Report on Shift from Infrastructure-Centric to Application-Centric IT Management 2Health News:JumpSoft Releases Report on Shift from Infrastructure-Centric to Application-Centric IT Management 3
... The same type of change that has come ... to U.S. Preventive Medicine, the leader in prevention.(Logo: ... faces and policies to our capital, the time is ... approach to health care," said Christopher Fey, Chairman and ...
... FJC, a foundation of philanthropic donor-advised funds and the ... the "Cure Myeloma Project", an ongoing research initiative at ... in Los Angeles, CALOS ANGELES, Jan. 26 IMBCR,s ... find a cure for multiple myeloma, a blood cancer ...
... form strong connections to particular product brands,when their ... to a new study in the, Journal of ... of Wisconsin-Madison and Korea,University), James E. Burroughs (University ... levels of materialism and insecurity,in consumers and discovered ...
... discount on the initial franchise fee and a place ... Jan. 26 Despite the challenging economic climate in ... experienced retail employees their jobs - the supplement and ... to grow at a rate of 4%-6% each year, ...
... incentives to foster healthy choices.LYNDHURST, N.J., Jan. 26 ... solutions to the healthcare industry, announced today that ... a new "points-based" health incentive program with IncentOne,s ... employers ways to motivate their employees toward improved ...
... in their twenties and thirties are more likely to develop ... study of more than 800 men published in the January ... research team also found that frequent sexual activity in a ... levels of activity in a man,s fifties could offer protection ...
Cached Medicine News:Health News:U.S. Preventive Medicine Recommends Changing CDC Name to Centers for Disease Prevention and Control 2Health News:1.2 Million Dollars Recently Awarded to Institute for Myeloma and Bone Cancer Research 2Health News:Security blankets: Materialism and death anxiety lead to brand loyalty 2Health News:Lost Your Job in Retail? Why Not Operate Your Own Business in 2009! Invest in You. Become an Entrepreneur! 2Health News:Lost Your Job in Retail? Why Not Operate Your Own Business in 2009! Invest in You. Become an Entrepreneur! 3Health News:IncentOne Provides Incentive Solution to CIGNA 2Health News:Frequent sex and masturbation in 20s and 30s linked to higher prostate cancer risk 2Health News:Frequent sex and masturbation in 20s and 30s linked to higher prostate cancer risk 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: